An innovative project of Mount Sinai Medical Center in New York City, HepCure is improving provider knowledge & patient engagement for chronic disease management in persons infected with the Hepatitis C Virus (HCV). The toolkit is designed to address barriers for the effective care and treatment of HCV by providing web-based and smartphone enabled resources, navigation, consultation, and support for both patients and providers. The HepCure toolkit draws upon the experience of expert providers within the Mount Sinai Network, with support and development by Sinai AppLab, Mount Sinai Medical Center. HepCure was developed by the Mount Sinai Division of Liver Diseases, Division of General Internal Medicine, and the Informatics for Research, Outcomes, and Quality initiative in the Division of Gastroenterology.
HepCure is a secure, cloud-based provider portal meant to virtually navigate providers through hepatitis C virus (HCV) care. The HepCure dashboard integrates tools to more effectively manage HCV infected patients. A flexible, scalable platform, the HepCure Dashboard provides a seamless flow of information within a digital healthcare infrastructure. HepCure enables easy access to HCV resources and best-practices for optimal management of HCV patients with the opportunity to engage patients on treatment, while improving overall health outcomes. The platform serves as an organizational tool, with built-in workflow efficiencies that optimize treatment decisions, reduce redundancies, as well as promote provider training and development.
Through the use of the dashboard and patient app, providers can:
We at HepCure are always looking for ways to improve. That’s why we’re constantly working on new features and meeting new challenges! Here are just a few of the features we plan to explore:
The patient app is a free resource for patients with hepatitis C, which allows them to track medication adherence, symptoms, and gain access to resources. It is available to download for free on iOS (App Store) and Android (Google Play) operating systems. While the app can be used by patients independently from the dashboard, it can also be linked with the provider dashboard. Providers can push lab data to patients and track treatment adherence and symptom data input by patients in real time.
The HepCure Tele-Education Webinar Series features many diverse and salient topics in hepatitis C. Each week, the webinar series showcases different speakers who are prominent members of the hepatitis C community. Our webinars are attended by a wide audience, and include providers, patient navigators, and other health workers from around the globe. Our collaboration with the New York State Clinical Education Initiative (CEI) and Empire Liver Foundation (ELF) allows us to provide continuing education credits (CME/CNE) through attendance to our webinars on the first and last Tuesday of every month.
All webinars are held on Tuesdays from 4:30 - 5:30pm EST
Please join us on Tuesday, January 16th at 4:30 PM EST for a presentation by Dr. Susanna Naggie, MHS, of Duke University Medical Center. Dr. Naggie will present:
“Hepatitis C Pre-Treatment Evaluation: A Guide for Clinicians”
1. Describe current Hepatitis C screening strategies and recommendations.
2. Discuss diagnostic algorithms and guidelines for confirmatory testing.
3. Review best practices for selecting a Hepatitis C treatment regimen.
Dr. Susanna Naggie completed her medical education at Johns Hopkins School of Medicine and her internal medicine training at Duke University Medical Center (DUMC), where she also served as a Chief Resident in Internal Medicine. She completed her Infectious Diseases (ID) fellowship training at Duke in July 2009 and then joined the faculty in the Division of ID. She is an Associate Professor of Medicine and currently holds appointments at DUMC, at the Duke Clinical Research Institute (DCRI, Director of ID Research), and at the Durham Veterans Affairs Medical Center (DVAMC). She currently leads two multidisciplinary HIV and viral hepatitis clinics, providing patient care to mono-infected and co-infected persons and developing research protocols relevant to the clinical care of this population. She completed her K23 work and has transitioned to independent R01 funding. She has also served as both site and national PI for clinical trials in HCV therapeutics. Dr. Naggie is a co-Chair of the AASLD/IDSA HCV Guidance Committee, and is a member of the AIDS Clinical Trials Group Viral Hepatitis Transformative Science Group Committee and the CDC/NIH/IDSA-HIVMA Opportunistic Infections Guideline Committee.
Continuing Nurse Education Credits
The University at Albany School of Public Health is an Approved Provider of continuing nurse education by the Northeast Multi-State Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
This offering is approved for 1.0 nursing contact hours.
Continuing Medical Education Credits
The School of Public Health, University at Albany is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians. The School of Public Health, University at Albany designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
On Tuesday, January 9th, Phillip Waters, JD, of the Center for Health Law and Policy Innovation at Harvard Law School presented on: “Hepatitis C: The State of Medicaid Access”
Phil joined the Harvard Law School Center for Health Law and Policy Innovation in October 2016 as a Clinical Fellow. His work focuses on advocating nationally to expand access to Hepatitis C cures in Medicaid and other health programs, collaborating with partners in the South to address health disparities, and keeping the community abreast of health policy reform proposals as they develop. Phil received his J.D. from the University of North Carolina School of Law, and is an active member of the North Carolina State Bar. During law school, Phil pursued various experiential opportunities in health law and public interest, including working as a summer associate with the National Health Law Program and serving as an extern for Legal Aid of North Carolina’s Medical-Legal Partnership. While at UNC, Phil worked for three years as a volunteer Healthcare Navigator and oversaw training and coordination of volunteer navigators from UNC with Legal Aid of North Carolina.
These learning modules are intended for clinicians of all backgrounds who may encounter or treat patients with hepatitis C and would like to establish core competencies in screening & diagnosis, evaluation and management of the disease. Content includes screening and linkage to care, initial evaluation, diagnosis and recognition of clinical manifestations. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
These learning modules are intended for clinicians who have experience treating patients with hepatitis C and would like to further their knowledge. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment
THe Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C) is a free interactive online tool that enables you to provide a thorough assessment of a patient’s psychosocial readiness to begin Hepatitis C treatment, and make a treatment plan to improve treatment readiness.
This free online tool can be used by any type of professional involved in preparing a patient for Hepatitis C Treatment including medical providers, nurses, mental health, substance use, social work, pharmacy, case management, treatment adherence and health education specialists.